Molecular analysis of the cutaneous Malassezia microbiota from the skin of patients with atopic dermatitis of different severities

Mycoses

Volumn 54, Issue 4, 2011, Pages

  Kaga, M ^a   Sugita, T ^b   Nishikawa, A ^b   Wada, Y ^b   Hiruma, M ^c   Ikeda, S ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

Author keywords

Atopic dermatitis; Malassezia; Real time PCR; Severity

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEAD AND NECK INFECTION; HUMAN; MALASSEZIA; MALASSEZIA DERMATIS; MALASSEZIA DERMATITIS; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA JAPONICA; MALASSEZIA OBTUSE; MALASSEZIA RESTRICTA; MALASSEZIA SLOOFFIAE; MALASSEZIA SYMPODIALIS; MALASSEZIA YAMATOENSIS; MALE; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN FLORA; SPECIES DIVERSITY;

ADULT; DERMATITIS, ATOPIC; DERMATOMYCOSES; FEMALE; HUMANS; MALASSEZIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SKIN;

MALASSEZIA; MALASSEZIA GLOBOSA; MALASSEZIA RESTRICTA;

EID: 79959278571     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01821.x     Document Type: Article

References (24)

1. Ashbee HR. Update on the genus Malassezia. Med Mycol 2007; 45: 287-303.
2. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002; 15: 545-63.
3. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004; 51: 785-98.
4. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study. Acta Derm Venereol 1995; 75: 46-9.
5. Ikezawa Z, Kondo M, Okajima M, Nishimura Y, Kono M. Clinical usefulness of oral itraconazole, an antimycotic drug, for refractory atopic dermatitis. Eur J Dermatol 2004; 14: 400-6.
6. Bayrou O, Pecquet C, Flahault A, Artigou C, Abuaf N, Leynadier F. Head and neck atopic dermatitis and Malassezia furfur-specific IgE antibodies. Dermatology 2005; 211: 107-13.
7. Schultz Larsen F, Svensson A, Diepgen TL, From E. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996; 34: 760-4.
8. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996; 69: 337-55.
9. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337-41.
10. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001; 39: 243-51.
11. Sandström Falk MH, Tengvall Linder M, Johansson C et al. The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005; 85: 17-23.
12. Sugita T, Suto H, Unno T et al. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol 2001; 39: 3486-90.
13. Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using real-time PCR. Microbiol Immunol 2006; 50: 549-52.
14. Takahata Y, Sugita T, Kato H, Nishikawa A, Hiruma M, Muto M. Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. Br J Dermatol 2007; 157: 1178-82.
15. Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008; 128: 345-51.
16. Kato H, Sugita T, Ishibashi Y, Nishikawa A. Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzyme-linked immunosorbent assay. Microbiol Immunol 2006; 50: 851-6.
17. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92: 4-47.
18. Morishita N, Sei Y, Sugita T. Molecular analysis of Malassezia microflora from patients with pityriasis versicolor. Mycopathologia 2006; 161: 61-65.
19. Hoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992; 165: 1064-8.
20. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 1999; 38: 265-9.
21. Stefania S, Giulia G. Objective assessment of the skin of children affected by atopic dermatitis. Acta Derm Venereol 1995; 75: 429-33.
22. Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283: 219-23.
23. Howell MD. The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 413-7.
24. Sugita T, Suzuki M, Goto S et al. Quantitative analysis of the cutaneous Malassezia microbiota in 770 healthy Japanese by age and gender using a real-time PCR assay. Med Mycol 2009; May 21: 1-5. Epub ahead of print